Chargement de votre page…
International archives of otorhinolaryngology
Par Aljeraisi T.
Contenu en anglais
There are limited evidence-based nasal therapies available to treat cluster headaches. Likewise, there are not many head-to-head treatment comparisons available because most clinical trials have only compared therapies versus placebos.
Ward réunit ces articles dans la même app que vos cartes et vos questions. Un seul compte gratuit pour Ward, Suture, Osler et Prognia.
To compare different nasal therapies for cluster headache.
We used four databases to search for records and then screened them for eligibility. In randomized studies, the risk of bias was assessed using the Cochrane tool for randomized clinical trials. The data were then retrieved and used in double-arm analyses using the R Software (free and open source). Zolmitriptan 10 mg and oxygen demonstrated the greatest efficacy for headache relief, while oxygen ranked highest for pain-free outcomes. Zolmitriptan 10 mg was most effective in reducing rescue medication use. Across outcomes, zolmitriptan 10 mg and oxygen consistently ranked as the most effective treatments, with no evidence of inconsistency.
Intranasal therapeutic sprays expand the treatment options and may provide better results, more rapid relief, and higher patient satisfaction than oral or injectable medications. Although many intranasal therapeutic sprays showed variable efficacy in cluster headache relief, more randomized controlled trials on a large sample of patients with a longer follow-up duration are needed.
Publié dans International archives of otorhinolaryngology. Le résumé est reproduit tel qu’il a été publié et reste l’œuvre de ses auteurs ; lisez l’article complet à la source.
Prognia référence cet article à des fins de documentation et de formation. Il ne constitue pas un avis médical. Lisez toujours l’original et suivez les recommandations en vigueur et les protocoles locaux avant d’agir.
